Anoto Digital Writing Ensures Reduction of Duplicated Information at University Hospital of Wales

AnotoAnoto, the creator of digital writing technology, has announced that the maternity department of University Hospital of Wales, part of Cardiff & Vale University Health Board, is using its digital pen technology to record results of foetal fibronectin (FFN) tests and digitise test results to reduce time spend on administration and ensure the hospital has digital records of test results.

Previously, University Hospital of Wales maternity services recorded FFN test information and results using handwritten notes, which would then be manually entered into three different records; the department records, the mother’s hospital records and to the handheld notes held by the mother. This resulted in delays in getting the information entered into systems and also lead to instances of lost information. If the handheld notes were lost or forgotten at the time of labour, midwives would have no other way of accessing all the necessary information they needed for a delivery.

"Previously, we had three separate records where we needed to record the test results," said Abigail Holmes, consultant midwife at University Hospital Wales. "We felt that we needed something that would allow us to keep both the paper record and have the information stored digitally as well, so that we had a record of the test results on a computer system once it was written in the handheld notes. Anoto's digital writing technology was ideal for this purpose as it allowed us to carry on using a familiar workflow but at the same time removed the need to re-enter data into different systems."

The test is usually carried out on mothers that are showing symptoms of pre-term labour between 24 and 34 weeks of pregnancy. The test is designed to help for a more accurate diagnosis in cases where pre-term labour is suspected. In case of a positive FFN test, midwives are able to administer medications that can potentially stall pre-term labour. "The testing is essential in cases where premature labour is suspected or a mother has previously delivered a baby prematurely," Holmes explained. "The testing allows us to take necessary steps to ensure that the baby has the best chances to survive after a premature delivery. The test allows us to provide the mother and baby with necessary medication."

Since deploying Anoto’s digital writing technology, University Hospital Wales has been able to significantly reduce the triplication of data as well as make the information available to midwives in an electronic format at all times.

"The digital pen technology has allowed us to record the information both in writing and in an electronic format, meaning that we don’t have to record the information multiple times, which is a huge time saver for us," Holmes said. "Additionally, in the cases where handheld notes containing the test result are lost or forgotten, midwives will have access to the information in an electronic format, ensuring that during labour all the information is available to them, on paper and digitally."

"Digital writing technology is an ideal technology that can be used to significantly reduce administrative burdens," said Richard Sargent, project delivery director at Anoto Ltd. "Not only does digital writing free more time for patient care but also enables hospitals to have a digital record of all patient-related notes and tests readily available in cases where paper-based notes could potentially be misplaced. In the FFN testing, digital writing technology has allowed the team at University Hospital of Wales to reduce administrative time whilst keeping to the existing workflow."

About Anoto Group
Anoto Group AB is a global leader in digital writing solutions, which enables fast and reliable transmission of handwriting into a digital format. Anoto operates worldwide through a global partner network that delivers user-friendly digital writing solutions for efficient capture, transmission, distribution and storage of data. Anoto is currently in use across multiple business segments, e.g. healthcare, pharmaceutical, bank and financial services, transportation and logistics, government and education. The Anoto Group has over 100 employees and is headquartered in Lund (Sweden), with offices in Basingstoke, Guildford and Wetherby (UK), Amsterdam (NL), Boston (US) and Tokyo (Japan). The Anoto share is traded on the Small Cap list of NASDAQ OMX Stockholm under the ticker ANOT.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...